O. Zehou

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 303 citations · Full text

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2020 · 168 citations

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review

O. Zehou, Elizabeth Fabre, Laurent Zelek et al. · Orphanet Journal of Rare Diseases · 2013 · 90 citations · Full text

Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey

C. Lesage, Christine Longvert, S. Prey et al. · Journal of Immunotherapy · 2019 · 73 citations

Immunodeficiencies, Immunology, Immune Regulation +23

Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients—Exposed/Unexposed and Propensity Score-Matched Analyses

F. Poizeau, O. Gaudin, Laurence Le Cleach et al. · Journal of Investigative Dermatology · 2018 · 57 citations

Beneficial Effect, Clinical Epidemiology, Clinical Trials +9